Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-07-10, Stock:PFE, The news for the past five days is as follows:
2019-07-02: NEWS1: Pfizer's Eucrisa Proves Safety in Kids with Atopic Dermatitis.NEWS2: Pfizer's Eucrisa Proves Safety in Kids with Atopic Dermatitis.NEWS3: Pfizer's Eucrisa Proves Safety in Kids with Atopic Dermatitis.NEWS4: A recession-proof industry you can count on: pet care.NEWS5: 3 Dow Jones Stocks to Buy for the Second Half.NEWS6: Ex-FDA Chief Scott Gottlieb Defends Return To Private Sector, Warren Calls For Resignation.NEWS7: GSK hikes price of subsidiary Tesaro's ovarian cancer drug.NEWS8: Senator Warren asks former FDA chief Gottlieb to resign from Pfizer board.NEWS9: Company News for Jul 2, 2019.NEWS10: Company News for Jul 2, 2019.NEWS11: Sen. Elizabeth Warren Urges New Pfizer Board Member Gottlieb to Resign.NEWS12: CORRECTED-Pfizer, Sanofi, to boost South African Biovac's vaccine output.NEWS13: Health Care Sector Update for 07/02/2019: AMRN, CUR, IOVA, JNJ, PFE, ABT, MRK, AMGN.NEWS14: Health Care Sector Update for 07/02/2019: AMRN, CUR, IOVA, JNJ, PFE, ABT, MRK, AMGN.NEWS15: Company News for Jul 2, 2019.NEWS16: Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for July 03, 2019.NEWS17: Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for July 03, 2019.NEWS18: Pfizer, Sanofi, to boost South African Biovac's vaccine output.NEWS19: GSK-Pfizer JV gets conditional approval from S.Africa's competition regulator.
2019-07-03: NEWS1: Pfizer (PFE) Gains But Lags Market: What You Should Know.NEWS2: Pfizer (PFE) Gains But Lags Market: What You Should Know.NEWS3: Pfizer (PFE) Gains But Lags Market: What You Should Know.NEWS4: Notable ETF Inflow Detected - VOO, BRK.B, PFE, DIS.NEWS5: Notable ETF Inflow Detected - VOO, BRK.B, PFE, DIS.NEWS6: 3 Big Stock Charts for Wednesday: CVS Health, Pfizer and Weyerhaeuser.NEWS7: 3 Big Stock Charts for Wednesday: CVS Health, Pfizer and Weyerhaeuser.NEWS8: Biotech Braces for Busy Summer as 2019 M&A Volume Heats Up.NEWS9: Will the Pharma Space Witness More Mega-Merger Deals in 2H?.NEWS10: Sanofi a Top Ranked SAFE Dividend Stock With 3.9% Yield (SNY).NEWS11: Sanofi a Top Ranked SAFE Dividend Stock With 3.9% Yield (SNY).NEWS12: Trump's Bully Pulpit Didn’t Stop Drug-Price Hikes.NEWS13: 3 Big Stock Charts for Wednesday: CVS Health, Pfizer and Weyerhaeuser.
2019-07-05: NEWS1: June jobs report crushes expectations as Fed weighs a rate cut.NEWS2: Why Putting the Former Head of the FDA On Pfizer’s Board Is So Fraught.NEWS3: Pharma Stock Roundup: PFE's Regulatory/Pipeline Updates, CHMP Nod for Several Drugs.NEWS4: Pharma Stock Roundup: PFE's Regulatory/Pipeline Updates, CHMP Nod for Several Drugs.NEWS5: Dow 30 Stock Roundup: Visa to Buy Verifi, Goldman May Launch Own Cryptocurrency.NEWS6: Health Care Sector Update for 07/05/2019: TYME, CYAD, GRFS, JNJ, PFE, ABT, MRK, AMGN.NEWS7: Health Care Sector Update for 07/05/2019: TYME, CYAD, GRFS, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Pharma Stock Roundup: PFE's Regulatory/Pipeline Updates, CHMP Nod for Several Drugs.NEWS9: Dow 30 Stock Roundup: Visa to Buy Verifi, Goldman May Launch Own Cryptocurrency.
2019-07-08: NEWS1: What Happened in the Stock Market Today.NEWS2: Health Care Sector Update for 07/08/2019: SOLY,PRVL,SGMO,ITCI.NEWS3: Health Care Sector Update for 07/08/2019: SOLY,PRVL,SGMO,ITCI.NEWS4: Gene Therapy Battle: Why Sangamo Therapeutics Is Thrashing Its Rivals.NEWS5: Sangamo Therapeutics News: SGMO Stock Surges on Gene Therapy Study.NEWS6: Here's Why Sangamo Therapeutics Is Surging Today.NEWS7: Here's Why Sangamo Therapeutics Is Surging Today.NEWS8: Health Care Sector Update for 07/08/2019: PRVL,SGMO,ITCI.NEWS9: Health Care Sector Update for 07/08/2019: PRVL,SGMO,ITCI.NEWS10: Why Bristol-Myers Squibb Stock Plunged in the First Half of 2019.NEWS11: Why Bristol-Myers Squibb Stock Plunged in the First Half of 2019.NEWS12: Pfizer Looks Pretty Smart With Array BioPharma Purchase. Here’s Why..NEWS13: Johnson & Johnson: How Does Darzalex Compare To Other Multiple Myeloma Drugs?.NEWS14: Johnson & Johnson: How Does Darzalex Compare To Other Multiple Myeloma Drugs?.NEWS15: Why Exact Sciences Corporation Stock Gained Nearly 14% in June.NEWS16: Health Care Sector Update for 07/08/2019: SGMO, PFE, ITCI, PRVL, JNJ, ABT, MRK, AMGN.NEWS17: Health Care Sector Update for 07/08/2019: SGMO, PFE, ITCI, PRVL, JNJ, ABT, MRK, AMGN.NEWS18: Pfizer Is Looking Pretty Smart With Array BioPharma Purchase.
2019-07-09: NEWS1: Aerie Completes Enrollment Under Rhopressa Study in Japan.NEWS2: Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know.NEWS3: BioMarin (BMRN) to File for Hemophilia A Candidate in Q4.NEWS4: BioMarin (BMRN) to File for Hemophilia A Candidate in Q4.NEWS5: Sangamo Up As Gene Therapy Shows Promise in Hemophilia Study.NEWS6: Sangamo Up As Gene Therapy Shows Promise in Hemophilia Study.NEWS7: Glaxo's Long-Acting HIV Regimen Gets FDA's Priority Status.NEWS8: Glaxo's Long-Acting HIV Regimen Gets FDA's Priority Status.NEWS9: Dow Movers: MMM, MRK.NEWS10: Dow Movers: MMM, MRK.NEWS11: Judge rules against Trump on drug pricing disclosures.NEWS12: Amarin Thinks Sales of Its Cardio Drug Could Be in the Billions.NEWS13: Sangamo Up As Gene Therapy Shows Promise in Hemophilia Study.NEWS14: BioMarin (BMRN) to File for Hemophilia A Candidate in Q4.NEWS15: Women Health a Top Priority Now: 3 Stocks to Watch.NEWS16: Women Health a Top Priority Now: 3 Stocks to Watch.NEWS17: Glaxo's Long-Acting HIV Regimen Gets FDA's Priority Status.NEWS18: Health Care Sector Update for 07/09/2019: CHEK, ALT, IMMP, JNJ, PFE, ABT, MRK, AMGN.NEWS19: Health Care Sector Update for 07/09/2019: CHEK, ALT, IMMP, JNJ, PFE, ABT, MRK, AMGN.NEWS20: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS21: Women Health a Top Priority Now: 3 Stocks to Watch.NEWS22: Sangamo Therapeutics News: SGMO Stock Surges on Gene Therapy Study.NEWS23: Sangamo Therapeutics News: SGMO Stock Surges on Gene Therapy Study.

Answer: Rise